European guideline for the management of hepatitis B and C virus infections

Roure C . Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995; 13 (suppl 1): S1821

Van Damme P , Tormans G , Beutels P Hepatitis B prevention in Europe: a preliminary economic evaluation. Vaccine 1995; 13 (suppl 1): S547

Adamo B , Stroffolini T , Sagliocca I Ad hoc survey of hepatitis B vaccination campaign in newborns of HBsAg positive mothers and in 12-year-old subjects in southern Italy. Vaccine 1998; 16: 7757

Chiarmonte M , Pupa A , Menegon T HBV and HCV among non-European Union immigrants in North-East Italy. Epidemiol Infect 1998; 121: 17983

Osella AR , Massa MA , Joekes S Hepatitis B and C virus sexual transmission among homosexual men. Am J Gastroenterol 1998; 93: 4952

Gilson RJ , de Ruiter A , Waite J Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Trans Inf 1998; 74: 11015

Ward H , Day S , Weber J . Risky business: health and safety in the sex industry over a 9 year period. Sex Trans Infect 1999; 75: 3403

Hart GJ , Dawson J , Fitzpatrick RM Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992. AIDS 1993; 7: 8639

Davis LG , Weber DJ , Lemon SM . Horizontal transmission of hepatitis B virus. Lancet 1989; i: 88993

Hoofnagle JH . Chronic hepatitis B. N Engl J Med 1990; 323: 3379

Osella AR , Massa MA , Joekes S Hepatitis B and C virus transmission among homosexual men. Am J Gastroenterol 1998; 93: 4952

Struve J , Giesecke J , Lindh G Heterosexual contact as a major route for transmission of acute hepatitis B amongst adults. J Infect 1990; 20: 11121

Balogun MA , Ramsay ME , Fairley CK , Collins M , Heptonstall J . Acute hepatitis B infection in England and Wales: 1985-96. Epidemiol Infect 1999; 122: 12531

Huo TI , Wu JC , Huang YH Evidence of transmission of hepatitis B to spouses from sequence analysis of the viral genome. J Gastroenterol Hepatol 1998; 13: 113842

Hyams KC , Phillips IA , Tejada A . Hepatitis B in a highly active prostitute population: evidence for a low risk of antigenaemia. J Infect Dis 1990; 162: 2958

Salisbury TM , Begg N , eds. Hepatitis B. In: Immunisation Against Infectious Disease. London: HMSO, 1996: 95108

Palmovich D , Crnjakovic-Palmovic J Prevention of hepatitis B virus (HBV) infection in healthcare workers after accidental exposure: a comparison of two prophylactic schedules. Infection 1993; 21: 425

Brook MG , Lever AML , Griffiths P Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: Three years experience in a London hospital. Q J Med 1989; 264: 31317

Cramp ME , Grundy HC , Perinpanayagam RM Seroprevalence of hepatitis B and C virus in two institutions caring for mentally handicapped adults. J Soc Med 1996; 89: 4012

Kiire CF . The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and sub-tropical Africa. Gut 1996; 38 (suppl 2): S512

McIntyre N . Clinical presentation of acute viral hepatitis. Br Med Bull 1990; 46: 53347

Hyams KC . Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 9921000

Giflin N . Hepatitis B: diagnosis, prevention and treatment. Clin Chem 1997; 43: 15006

Brook MG , Chan G , Yap I Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989; 299: 6526

Brook MG , McDonald JA , Karayiannis P , Caruso L , Forster G , Thomas HC . Randomised controlled trial of interferon alfa 2a (rbe) (Roferon A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Gut 1989; 30: 111622

Brook MG , Karayiannis P , Thomas HC . Which patients with chronic hepatitis B will respond to alpha interferon therapy? A statistical analysis of predictive factors. Hepatology 1989; 10: 7613

Nevens F , Main J , Honkoop P Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997; 113: 125863

McPherson RA . Laboratory diagnosis of human hepatitis viruses. J Clin Lab Anal 1994; 8: 36977

el-Dalil A , Radcliffe KW , Bailey J A survey on hepatitis B vaccination policies in genitourinary medicine in the UK and Ireland. Genitourin Med 1995; 71: 2513

Gilson RJC , Anderson J , Brink N Hepatitis B Screening and Immunisation in Genitourinary Medicine Clinics. London: North Thames Regional Audit, 1994

Sutherland S , Tilzey A . Guidelines for Hepatitis B Screening and Vaccination. London: South Thames (East) Genitourinary Medicine Audit Group, 1993

Allain JP , Hewitt PE , Tedder RS , Williamson LM . Evidence that anti-HBc but not HBV-DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999; 107: 18695

Gutierrez C , Leon G , Loureiro CL Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen. Clin Diagnostic Lab Immunol 1999; 6: 76870

Jefferson T , Demicheli V , Deeks J Vaccines against hepatitis B in healthcare workers. Systematic Review. Cochrane Library: Last amended 30 April 1997

Francis DP , Hadler SC , Thompson SE The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multi-center trial among homosexual men. Ann Int Med 1982; 97: 3626

Lai CL , Ching CK , Tung AK Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatol 1997; 25: 2414

Main J , Brown JL , Howells C A double-blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Vir Hepatitis 1996; 3: 21115

Bhave G , Lindan CP , Hudes ES Impact of an intervention on HIV, sexually transmitted diseases and condom use among sex workers in Bombay. AIDS1995; 9 (suppl)10: S2130

Van Damme P , Kane M , Meheus A Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board. BMJ 1997; 314: 10336

Wong KL , Bodsworth NJ , Slade MA Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 1996; 7: 4904

Tayal SC , Sankar KN . Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS 1994; 8: 5589

Rey D , Krantz V , Partisani M Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 2000; 18: 11615

European consensus group on hepatitis B immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000; 355: 5615

Clemens R , Sanger R , Kruppenbacher J Booster immunisation of low- and non-responders after a standard three dose hepatitis B vaccine schedule — results of post-marketing surveillance. Vaccine 1997; 15: 4952

Goldwater PN . Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997; 15: 3536

Haubitz M , Ehlerding G , Beigel A Clinical experience with a new recombinant hepatitis B vaccine in previous non-responders with chronic renal insufficiency. Clin Nephrol 1996; 45: 1802

Zuckerman JN , Sabin C , Craig FM Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double-blind dose-response study. BMJ 1997; 314: 32933

Heineman TC , Clements-Mann ML , Poland GA A randomized controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvent. Vaccine 1999; 17: 276978

Zuckerman JN . Hepatitis B third generation vaccines: improved response and conventional vaccine non-response — third generation pre-S/S vaccines overcome non-response. J Viral Hep 1998; 5 (suppl 2): 1315

Eyigun CP , Yilmaz S , Gui C A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and pre-subunit vaccine for immunization of healthy adults. J Viral Hep 1981; 5: 2659

Wistrom J , Ahlm C , Lundberg S , Settergren B , Tarnvik A . Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999; 17: 21625

Marsano LS , West DJ , Chan I A two dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults. Vaccine 1998; 16: 6249

Jack AD , Hall AJ , Maine N , Mendy M , Whittle HC . What level of hepatitis B antibody is protective? J Infect Dis 1999; 179: 48992

Yuen MF , Lim WL , Cheng CC , Lam SK , Lai CL . Twelve year follow-up of a prospective randomized trial of recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Hepatology 1999; 29: 9247

Wainwright RB , Bulkow LR , Parkinson AJ , Zanis C , McMahon BJ . Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J Infect Dis 1997; 175: 6747

Janssen HL , Gerken G , Carreno V Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1999; 30: 23813

Carreno V , Marcellin P , Hadziyannis S Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1999; 30: 27782

Chien RN , Liaw YF , Chen TC Efficacy of thymosin alpha 1 in patients with chronic hepatitis B: a randomized controlled trial. Hepatology 1998; 27: 13837

Lai CL , Chien RN , Leung NW A one-year trial of lamivudine for chronic hepatitis B. Asia Lamivudine Study Group. New Engl J Med 1998; 339: 618

Dienstag JL , Schiff ER , Wright TL Lamivudine as initial treatment of chronic hepatitis B in the United States. N Engl J Med 1999; 341: 125663

Marques AR , Lau DT , McKenzie R , Straus SE , Hoofnagle JH . Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. J Infect Dis 1998; 178: 14837

Tsiang M , Rooney JF , Toole JJ , Gibbs CS . Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 1999; 29: 18639

Cotonat T , Quiroga JA , Lopez-Alcorocho JM Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients. Hepatology 2000; 31: 5026

Wong JB . Interferon treatment for chronic hepatitis B and C infection: costs and effectiveness. Acta Gastroenterol Belg 1998; 61: 23842

Ikeda K , Saitoh S , Suzuki Y Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer 1998; 82: 82735

Lin SM , Sheen IS , Chien RN , Chu CM , Liaw YF . Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999; 29: 9715

Thibault V , Benhamou Y , Seguret C Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol 1999; 37: 301316

Dore GJ , Cooper DA , Barrett C Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized controlled study (CAESAR). The CAESAR Coordinating Committee. J Infect Dis 1999; 180: 60713

Rayes N , Seehofer D , Bechstein WO Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation. Clin Transplant 1999; 13: 44752

Manns MP , Schuler A . Risk of hepatitis A superinfection in patients with underlying liver disease. Act Gastroenterol Belg 1998; 61: 2069

Andre FE , Zuckerman AJ . Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44: 14451 [Reviewed in the Cochrane Library]

Oxman AD , Scott EA , Sellors JW Partner notification for sexually transmitted diseases: an overview of the evidence. Canadian J Pub Health 1994; 85 (suppl 1): S417[Reviewed in the Cochrane Library]

Anon. Specific immunoglobulin in the prevention of hepatitis B. Lancet 1975; ii: 11324

Mele A , Franco E , Caprilli F Hepatitis B and delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J Epidem 1988; 4: 4889

Fagan EA , Williams R . Fulminant viral hepatitis. Br Med Bull 1990; 46: 46280

Richard V . Épidémiologie des hépatities C dans le monde. Méd Trop 1996; 56: 3939

Goldberg D , Cameron S , McMenamin J . Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Comm Dis Public Health 1998; 1: 957

Hillemans P , Langenegger P , Langer BC Pravalenz und Verlauf der Hepatitis C-Virusinfektion in der Schwangerschaft. Z Geburschilfe Neonatol 1998; 202: 12730

Garcia-Fulgueiras A , Tormo MJ , Rodriguez T Prevalence of hepatitis B and C markers in south-east Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis 1996; 28: 1720

Lamden KH , Kennedy N , Beeching NJ Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infect 1998; 37: 2609

Kaldor JM , Archer GT , Buring ML Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992; 157: 22730

Hoofhagle J . Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (suppl 1): 15S20S

Seeff LB . Natural history of hepatitis C. Hepatology 1997; 26 (suppl 1): 21S28S

Ramsay ME , Balogun MA , Collins M , Balraj V . Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992-1996. Comm Dis Pub Health 1998; 1: 8994

Hamid SS , Farooqui B , Rizvi Q , Sultana T , Siddiqui AA . Risk of transmission and features of hepatitis C after needlestick injuries. Infect Control Hosp Epidemiol 1999; 20: 634

Sawayama Y , Hayashi J , Kakuda K Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Digest Dis Sci 2000; 45: 3516

Guadagnino V , Stroffolino T , Foca A Hepatitis C virus infection in family setting. Eur J Epidemiol 1998; 14: 22932

Rooney G , Gilson RJC . Sexual transmission of hepatitis C virus infection. Sex Transm Inf 1998; 74: 399404

Dienstag JL . Sexual and perinatal transmission of hepatitis C. Hepatology 1997; 26 (suppl 1): 66S70S

Tedder RS , Gilson RJC , Briggs M Hepatitis C virus: evidence for sexual transmission. BMJ 1991; 302: 1299302

Bodsworth NJ , Cunningham P , Kaldor J Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med 1996; 72: 11822

Akahane Y , Kojima M , Sugai Y Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120: 74852

Zylberberg H , Pol S . Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996; 23: 111725

Neumayr G , Propst A , Schwaighofer H , Judmaier G , Vogel W . Lack of evidence for the heterosexual transmission of hepatitis C. QJM 1999; 92: 5058

Guadagnino V , Stroffolini T , Foca A Hepatitis C virus infection in a family setting. Eur J Epidemiol 1998; 14: 22932

Satoglu N , Tasova Y , Butgut R , Dun dar IH . Sexual and non-sexual intrafamilial spread of hepatitis C virus: intrafamilial transmission of HCV. Eur J Epidemiol 1998; 14: 2258

Mesquita PE , Granato CF , Castelo A . Risk factors associated with hepatitis C virus (HCV) infection among prostitutes and their clients in the city of Santos, São Paulo state, Brazil. J Med Virol 1997; 51: 33813

Balasekaran R , Bulterys M , Jamal MM A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999; 94: 13416

Delage G , Infante-Rivrd C , Chiavetta JA Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case control study. Gastroenterol 1999; 116: 8939

Murphy EL , Bryzman SM , Glynn SA Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000; 31: 75662

Resti M , Azzari C , Mannelli F Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317: 43741

Mazza C , Ravaggi A , Rodella A Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission. J Med Virol 1998; 54: 1219

Kumar RM , Shahul S . Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 1998; 29: 1917

Resti M , Azzari C , Mannelli F Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 1998; 317: 43741

Papaevangelou V , Pollack H , Rochford G Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis 1998; 178: 104752

Atrah HI , Ala FA , Ahmed MM Unexplained hepatitis C virus antibody seroconversion in established blood donors. Transfusion 1996; 36: 33943

Vento S , Garfano T , Renzini C Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 28690

Villano SA , Vlahov D , Nelson KE , Cohn S , Thomas DL . Persistence of virema and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 90814

Bonkovsky HL , Wooley JM . Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hematology 1999; 29: 2647

Rodger AJ , Jolley D , Thompson SC , Lanigan A , Crofts N . The impact of diagnosis of hepatitis C on quality of life. Hepatology 1999; 30: 1299301

Barkhuizen A , Rosen HR , Wolf S Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 1999; 94: 135560

Feucht HH , Zollner B , Schroter M High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up. J Clin Virol 1999; 13: 4351

Pol S , Lamorthe B , Thi NT Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 1998; 28: 94550

Wiley TE , McCarthy M , Breidi L , McCarthy M , Lay den TJ . Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 8059

Chiaramonte M , Stroffolini T , Vian A Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 21327

Chu CM , Yeh CT , Liaw YF . Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45: 61317

Van Thiel DH , Caraceni P , Molloy PJ Chronic hepatitis C in patients with normal or near normal aminotransferase levels: the role of interferon alpha 2b therapy. J Hepatol 1995; 23: 5038

Bellentani S , Pozzato G , Saccoccio G Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44: 87480

Gretch DR . Diagnostic tests for hepatitis C. Hepatology 1997; 26 (suppl 1): 43S47S

Lok ASF , Gunaratnam NT . Diagnosis of hepatitis C. Hepatology 1997; 26 (suppl 1): 48S56S

Pawlotsky JM , Lonjon I , Hezode C What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27: 17002

French consensus conference on hepatitis C: screening and treatment. Gut 1998; 42: 8928

Mohan KV , Murkavel KG , Rajaninkanth R Diagnosis of hepatitis C virus infection by ELISA, RIBA and RT-PCR: a comparative evaluation. Ind J Gastroenterol 1999; 18: 735

Dore GJ , Kaldor JM , McCaughan W . Systematic review of role of polymerase chain reaction in defining infectiousness in people infected with hepatitis C virus. BMJ 1997; 31: 3337

Roth WK , Lee JH , Ruster B Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method. Zeit Gastroenterol 1998; 36: 511

Alter M . Epidemiology of hepatitis C. Hepatology 1997; 26 (suppl 1): 62S65S

Anon. Hepatitis C virus: guidance on the risks and current management of occupational exposure. PHLS hepatitis subcommittee. CDR Review 1993; 3: R1359

Regan FA , Hewitt P , Barbara JA , Contreras M . Prospective investigation of transfusion transmitted infection in recipients of over 20,000 units of blood. BMJ 2000; 320: 4036

Hagan H , Mcgough JP , Thiede H Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149: 20313

Goldberg D , Cameron S , McMenamin J . Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Comm Dis Public Health 1998; 1: 957

van Beek I , Dwyer R , Dore GJ , Luo K , Kaldor JM . Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 31: 4337

National Institutes of Health Consensus Development Panel. National Institutes of Health consensus development conference panel statement: management of hepatitis C. Hepatology 1997; 26 (suppl 1): 2S10S

Expert Perspectives Panel. Strategies for the management of HIV/HCV co-infection [www.projectsinknowledge.com/hiv-hcv/index.html]

Vogel W , Graziadei I , Datz C High-dose interferon-alpha 2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 1996; 41 (suppl 12): 81S85S

Oketani M , Higashi T , Yamasaki M Complete response to twice-a-day interferon-beta with standard interferon-alpha therapy in acute hepatitisC after a needle-stick. J Clin Gastroenterol 1999; 28: 4951

Takagi H , Uehara M , Kakizaki S Accidental transmission of HCV and treatment with interferon. J Gastroenterol Hepatol 1998; 13: 23843

Farrell GC , Bacon BR , Goldin RD . Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study. Hepatology 1998; 27: 11217

Davis GL , Lau JYN . Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997; 26 (suppl 1): 122S127S

Schalm SW , Hansen BE , Chemello L Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centres. J Hepatol 1997; 26: 9616

Bardelli F , Messori A , Rampazzo R Effect of recombinant or lymphoblastoid interferon-alpha on alanine aminotransferase in patients with chronic hepatitis C or chronic non-A non-B hepatitis: a meta-analysis. Drug Invest 1995; 9: 23954 [Reviewed in the Cochrane Library]

Poynard T , Leroy V , Cohard M Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 77889 [Reviewed in the Cochrane Library]

Niederau C , Heintges T , Haussinger D Treatment of chronic hepatitis C with alpha-interferon: an analysis of the literature. Hepatol Gastroenterol 1996; 43: 154450 [Reviewed in the Cochrane Library]

Reichard O , Norkrans G , Fryden A Randomized, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet 1998; 351: 837

Reichard O , Norkrans G , Fryden A Randomized, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 837

McHutchison JG , Gordon SC , Schiff ER Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 148592

Poynard T , Marcellin P , Lee SS Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 142632

Sherman KE , Sjogren M , Creager RI Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized placebo-controlled double-blind trial. Hepatology 1998; 27: 112835

Davis GL , Esteban-Mur R , Rustgi V Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 14939

Martinot-Peignoux M , Boyer N , Pouteau M Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 1998; 29: 21423

Brouwer JT , Nevens F , Kleteer B Efficacy of interferon dose and prediction of response in chronic hepatitis C. Benelux study in 336 patients. J Hepatol 1998; 28: 9519

Bellobueno A , Mondazzi L , Tempini S Should patients with early loss of HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months? J Hepatol 1999; 30: 813

Kagawa T , Hosoi K , Takashimuzi S Comparison of two interferon alfa treatment regimens characterized by an early virological response in patients with chronic hepatitis C. Am J Gastroenterol 1998; 93: 1926

Montalto G , Soresi M , Carroccio A Comparative responses to three different types of interferon-alpha in patients with chronic hepatitis C. Curr Med Res Opin 1998; 14: 23541

Soriano V , Gacia-Samaniego J , Bravo R Efficacy and safety of alpha-interferon for chronic hepatitis C in HIV-infected patients. HIV-hepatitis Spanish study group. J Infect 1995; 31: 913

Mauss S , Klinker H , Ulmer A Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with Higher CD4+ cell count. Infection 1998; 26: 1619

Sangiovanni A , Morales R , Spinzi G Interferon alfa treatment of HCV-RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study. Hepatology 1998; 27: 8536

Mathurin P , Moussali J , Cadranel JF Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998; 27: 91419

Polywka S , Schroter M , Feucht HH , Zollner B , Laufs R . Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis 1999; 29: 13279

Kumar RM , Shahul S . Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 1998; 29: 1917